Yale University

Publications

Filters: Author is Andrews, Laurie  [Clear All Filters]
2002
Rainey, Petrie M., Gerald H. Friedland, Jerry W. Snidow, Elinore F. McCance-Katz, Susan M. Mitchell, Laurie Andrews, Barbara Lane, and Peter Jatlow. "The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 1 (2002): 66-74. Abstract
2005
Friedland, Gerald, Laurie Andrews, Tanya Schreibman, Sangeeta Agarwala, Leith Daley, Michael Child, Julia Shi, Yonghua Wang, and Edward O'Mara. "Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
2006
Mannheimer, Sharon B., Edward Morse, John P. Matts, Laurie Andrews, Carroll Child, Barry Schmetter, and Gerald H. Friedland. "Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S41-7. Abstract
2009
Bruce, Douglas R., Frederick L. Altice, David E. Moody, Shen-Nan Lin, Wenfang B. Fang, John P. Sabo, Jan M. Wruck, Peter J. Piliero, Carolyn Conner, Laurie Andrews et al. "Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone." Drug and alcohol dependence 105, no. 3 (2009): 234-9. Abstract
2010
Bruce, Robert Douglas, Frederick L. Altice, David E. Moody, Gene D. Morse, Laurie Andrews, Shen-Nan Lin, Wenfang B. Fang, Qing Ma, and Gerald H. Friedland. "Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract
2011
Bruce, Douglas R., David E. Moody, Wenfang B. Fang, Diane Chodkowski, Laurie Andrews, and Gerald H. Friedland. "Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone." The American journal of drug and alcohol abuse 37, no. 4 (2011): 224-8. Abstract
2013
Douglas Bruce, R., David E. Moody, Diane Chodkowski, Laurie Andrews, Wenfang B. Fang, Jerdravee Morrison, Theresa L. Parsons, and Gerald H. Friedland. "Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment." The American journal of drug and alcohol abuse 39, no. 2 (2013): 80-5. Abstract